Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mirion Technologies (MIR)
NYSE:MIR
Holding MIR?
Track your performance easily
Earnings Data
Report Date
Feb 18, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.14Last Year’s EPS
$0.15Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 29, 2024
|% Change Since: 27.15%
|Next Earnings Date:Feb 18, 2025
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with strong revenue growth and strategic achievements in nuclear power and cancer care markets. However, it also highlighted challenges such as decreased order rates and specific market difficulties in radiation therapy. The debooking of a project in Turkey was noted, but overall, the positive aspects seem to outweigh the challenges.Company Guidance
During the Mirion Technologies Q3 2024 earnings call, the company reaffirmed its financial guidance for the year, highlighting key metrics such as $207 million in third-quarter revenue, representing an 8% year-over-year increase, and adjusted EPS at $0.08 per share. The adjusted EBITDA reached $45.7 million, showing an improvement of 180 basis points in margin compared to the previous year. The company's backlog was reported at $815 million, a 2% increase from the same quarter last year. Despite a 30% decline in third-quarter order rate compared to the prior year, after adjusting for large orders from Q3 2023, orders actually grew 13%. The company aims to maintain its adjusted EBITDA and EPS guidance, projecting $195 million to $205 million for EBITDA and $0.37 to $0.42 for EPS, while fine-tuning revenue growth expectations to 6% to 7% for the full year.Strong Revenue and Growth Metrics
Third quarter revenue was $207 million, an 8% increase compared to last year. Adjusted EPS was $0.08, and adjusted EBITDA was $45.7 million with a 180 basis point margin improvement.
Strategic Nuclear Power Deals
Significant nuclear power deals include Microsoft's recommissioning of the 3-mile Island Nuclear Power Plant and Amazon's agreements to generate up to 5 gigawatts of additional nuclear energy in the U.S. by the late 2030s.
Growth in Cancer Care Market
The nuclear medicine market saw a 16% growth in the quarter, with significant growth in radiopharmaceutical therapies such as PluviCto and Pilarified, with sales increases of approximately 50% and 30%, respectively.
Operational Performance Improvements
Medical EBITDA margin increased by 50 basis points to 34.7%, and Technologies EBITDA margin rose by 370 basis points. Net working capital days improved by approximately 10 days since Q3 of last year.
---
MIR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MIR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $14.07 | $14.75 | +4.83% |
| Aug 01, 2024 | $10.30 | $10.09 | -2.04% |
| Apr 30, 2024 | $10.87 | $10.20 | -6.16% |
| Feb 13, 2024 | $9.42 | $10.05 | +6.69% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Mirion Technologies (MIR) report earnings?
Mirion Technologies (MIR) is schdueled to report earning on Feb 18, 2025, TBA Not Confirmed.
What is Mirion Technologies (MIR) earnings time?
Mirion Technologies (MIR) earnings time is at Feb 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MIR EPS forecast?
MIR EPS forecast for the fiscal quarter 2024 (Q4) is $0.14.
---